CLENZIderm M.D. - Real Results
See how the CLENZIderm M.D. System can provide visible reductions in acne lesions in as little as 1 week.1
Reference: 1. Swinyer L, Investigator. A single-center, open-label study to evaluate the tolerability and efficacy of the optimized CLENZIderm M.D. System for the treatment of mild to moderate facial acne vulgaris. Protocol CLZ-003. 12-week final analysis, January 2012. Obagi Cosmeceuticals LLC. Data on file.